Wolterman Dan 4

What Happened

• Dan Wolterman, a director at Globus Medical (GMED), received an award of 15,000 derivative shares (options) on January 21, 2026. The reported acquisition price is $0.00 and the grant carries no immediate cash proceeds. Per the filing footnote, these options will vest on January 1, 2027.

Key Details

• Transaction date: January 21, 2026; Filing date: January 23, 2026 (filed within the typical 2-business-day window).
• Transaction type: Grant / award of derivative securities (Form 4 code A).
• Amount: 15,000 derivative shares (options); reported price: $0.00; total reported consideration: $0.
• Vesting: These options vest on January 1, 2027 (footnote F1).
• Shares owned after transaction: Not specified in the provided filing.
• No indication of tax withholding, 10b5-1 plan, or late filing in the provided details.

Context

• This was a compensation grant (options that vest in the future), not an open-market purchase or sale. Such awards are common for executive/director compensation and do not reflect an immediate cash investment or sale. The options cannot typically be exercised or sold until they vest on the stated date.